ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Glaxosmithkline Us Trading Limited

Glaxosmithkline Us Trading Limited is a liquidation company incorporated on 12 September 2018 with the registered office located in Liverpool, Merseyside. Glaxosmithkline Us Trading Limited was registered 7 years ago.
Status
Liquidation
In voluntary liquidation since 18 days ago
Company No
11566030
Private limited company
Age
7 years
Incorporated 12 September 2018
Size
Large
Turnover is over £54M
Balance sheet is over £27M
Confirmation
Submitted
Dated 29 September 2025 (3 months ago)
Next confirmation dated 29 September 2026
Due by 13 October 2026 (8 months remaining)
No changes occurred since incorporation
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (8 months remaining)
Contact
Address
C/O Bdo Llp, 5 Temple Square
Temple Street
Liverpool
L2 5RH
Address changed on 6 Jan 2026 (18 days ago)
Previous address was 79 New Oxford Street London WC1A 1DG United Kingdom
Telephone
Unreported
Email
Unreported
Website
People
Officers
2
Shareholders
1
Controllers (PSC)
1
Director • Irish • Lives in Ireland • Born in Feb 1964
Glaxo Group Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Glaxosmithkline Finance Plc
The Wellcome Foundation Limited is a mutual person.
Active
Glaxo Group Limited
The Wellcome Foundation Limited is a mutual person.
Active
Glaxosmithkline Research & Development Limited
Aidan Lynch is a mutual person.
Active
Glaxosmithkline Export Limited
Aidan Lynch is a mutual person.
Active
Viiv Healthcare Trading Services UK Limited
Aidan Lynch is a mutual person.
Active
Glaxosmithkline Intellectual Property Management Limited
The Wellcome Foundation Limited is a mutual person.
Active
Action Potential Venture Capital Limited
The Wellcome Foundation Limited is a mutual person.
Active
Glaxosmithkline Intellectual Property (No.3) Limited
The Wellcome Foundation Limited is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2019–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
Unreported
Decreased by £1.47M (-100%)
Turnover
£815.43M
Increased by £239.93M (+42%)
Employees
Unreported
Same as previous period
Total Assets
£192.07M
Increased by £45.17M (+31%)
Total Liabilities
-£165.02M
Increased by £38.6M (+31%)
Net Assets
£27.05M
Increased by £6.57M (+32%)
Debt Ratio (%)
86%
Decreased by 0.14% (-0%)
Latest Activity
Registered Address Changed
18 Days Ago on 6 Jan 2026
Voluntary Liquidator Appointed
18 Days Ago on 6 Jan 2026
Declaration of Solvency
18 Days Ago on 6 Jan 2026
Confirmation Submitted
3 Months Ago on 29 Sep 2025
Andrew James Collier Resigned
5 Months Ago on 11 Aug 2025
Edinburgh Pharmaceutical Industries Limited Resigned
5 Months Ago on 11 Aug 2025
Neil Richard Wilkinson Resigned
5 Months Ago on 11 Aug 2025
Yvonne Margaret Stewart Resigned
5 Months Ago on 11 Aug 2025
Mark James Heathcote Resigned
5 Months Ago on 11 Aug 2025
Full Accounts Submitted
6 Months Ago on 10 Jul 2025
Get Credit Report
Discover Glaxosmithkline Us Trading Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Registered office address changed from 79 New Oxford Street London WC1A 1DG United Kingdom to C/O Bdo Llp, 5 Temple Square Temple Street Liverpool L2 5RH on 6 January 2026
Submitted on 6 Jan 2026
Appointment of a voluntary liquidator
Submitted on 6 Jan 2026
Resolutions
Submitted on 6 Jan 2026
Declaration of solvency
Submitted on 6 Jan 2026
Solvency Statement dated 05/11/25
Submitted on 10 Nov 2025
Statement of capital on 10 November 2025
Submitted on 10 Nov 2025
Resolutions
Submitted on 10 Nov 2025
Statement by Directors
Submitted on 10 Nov 2025
Confirmation statement made on 29 September 2025 with no updates
Submitted on 29 Sep 2025
Termination of appointment of Andrew James Collier as a director on 11 August 2025
Submitted on 21 Aug 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year